Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pevonedistat DDI with Fluconazole and Itraconazole in Advanced Solid Tumors
NCT02122770Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Apr 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pevonedistat in solid tumor (advanced stage) (2 arms), sponsored by Millennium Pharmaceuticals. Primary endpoints: Maximum Observed Plasma Concentration at Day 8, Area Under the Plasma Concentration-time Curve from Time 0 to Last Quantifiable Concentration at Day 8 and 1 more. Started Apr 2014; status: completed.
02
Drugs
pevonedistat
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT02122770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122770.